This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Alex Therien: Innovator in Biopharmaceuticals
Introduction
Alex Therien is a notable inventor based in Fanwood, NJ (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative solutions for medical challenges. His work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Alex Therien holds a patent for "C.difficile toxin B CROP domain peptides, antibodies and complexes thereof." This invention provides polypeptide domains of toxin B (B1, B2, B3, B4) and complexes between the polypeptides and antibodies that bind specifically to the polypeptide. The patent also outlines methods for using these polypeptides to generate antibodies, showcasing his commitment to advancing medical science.
Career Highlights
Therien is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the field. His work has been instrumental in developing new therapeutic approaches that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Nicholas J Murgolo and Lorraine Hernandez. Their collaborative efforts contribute to the innovative environment at Merck, fostering advancements in biopharmaceutical research.
Conclusion
Alex Therien's contributions to the field of biopharmaceuticals through his patent and work at Merck Sharp & Dohme Corporation highlight his role as an influential inventor. His dedication to innovation continues to pave the way for new medical solutions.